Pond Healthcare Innovation Develops Symptom Tracker for Novartis

Pond Healthcare Innovation has created a symptom tracker app for Novartis (NYSE:NVS) to support multiple sclerosis patients. The app will also serve as a raining tool for physicians on Hyponatremia for Otsuka. Furthermore, the company’s latest collaboration with Novartis is a smart spirometer and companion app intended to evaluate lung function.
According to an article on MedCityNews:

The goal of these devices is to get a regular assessment of lung function so if there is a sudden change, physicians can intervene faster and reduce the need for hospitalization.
Pond Healthcare Innovation CEO Daniel Taub said in an interview that the Air Smart spirometer device is CE-certified by European regulators and is available in Europe. Taub said that it collaborated with Novartis’s on a COPD application for the device, but he believes it could be applied to a broader variety of respiratory conditions beyond Europe.
It plans to launch a version of the smartphone-enabled device for Android users in the first quarter of 2016. The company is also working on an application to diagnose asthma.

Click here to read the full article.